Tamara D Hew-Butler

Dr. Tamara D Hew-Butler

College of Education, Wayne State University, Detroit, MI 48202, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Clinical Journal of Sport Medicine
Verified
Journal Article
Closed access
Tamara D Hew-ButlerTamara D Hew-Butler
Tamara D Hew-Butler
Martin HoffmanMartin Hoffman
Martin Hoffman
KSKristin J Stuempfle
Kristin J Stuempfle
IRIan R Mbbs Rogers
Ian R Mbbs Rogers
NMNils G Morgenthaler
Nils G Morgenthaler
JVJoseph G Verbalis
Joseph G Verbalis
Objective: To evaluate changes in both the N-terminal (arginine vasopressin; AVP) and C-terminal (copeptin) fragments of the vasopressin prohormone before, during, and after an ultramarathon race and to assess vasopressin and copeptin concentrations in runners with and without hyponatremia. Design: Observational study. Setting: Three trials (2 sodium balance and 1 hyponatremia treatment) in 2 separate approximately 160-km footraces [Western States Endurance Run (WSER) and Javelina Jundred (JJ100)]. Participants: Six hyponatremic and 20 normonatremic runners; 19 finishers with 7 completing 100 km. Main Outcome Measures: Plasma AVP ([AVP]p), copeptin ([copeptin]p), sodium ([Na+]p), and protein (%plasma volume change; %PV) concentrations. Results: In the WSER Sodium Trial, a 3-fold prerace to postrace increase in both [AVP]p (0.7 ± 0.4 to 2.7 ± 1.9 pg/mL; P < 0.05) and [copeptin]p (10.3 ± 12.5 to 28.2 ± 16.3 pmol/L; nonsignificant) occurred, despite a 2 mEq/L decrease in [Na+]p (138.7 ± 2.3 to 136.7 ± 1.6 mEq/L; NS). A significant correlation was noted between [AVP]p and [copeptin]p postrace (r = 0.82; P < 0.05). In the WSER Treatment Trial, despite the presence of hyponatremia pretreatment versus posttreatment ([Na+]p = 130.3 vs 133.5 mEq/L, respectively), both [AVP]p (3.2 vs 2.1 pg/mL) and [copeptin]p (22.5 vs 24.9 pmol/L) were well above the detectable levels. A significant correlation was noted between [AVP]p and [copeptin]p 60 minutes after treatment (r = 0.94; P < 0.05). In the JJ100 Sodium Trial, significant correlations were found between [copeptin]p change and %PV change (r = −0.34; P < 0.05) and between [AVP]p change and [Na+]p change (r = 0.39; P < 0.05) but not vice-versa. Conclusions [Copeptin]p seems to be a reliable surrogate of stimulated [AVP]p during exercise. Nonosmotic vasopressin stimulation occurs during ultradistance running. [Copeptin]p may better reflect chronic (%PV) vasopressin secretion under conditions of endurance exercise.

1 June 2010 in Sports Medicine
Verified
Journal Article
Closed access
PDF file
Tamara D Hew-ButlerTamara D Hew-Butler
Tamara D Hew-Butler

1 February 2018 in BMJ Open Sport & Exercise Medicine
Verified
Journal Article
Open access
PDF file
Tamara D Hew-ButlerTamara D Hew-Butler
Tamara D Hew-Butler
CEChristopher Eskin
Christopher Eskin
JBJordan Bickham
Jordan Bickham
MRMario Rusnak
Mario Rusnak
MVMelissa VanderMeulen
Melissa VanderMeulen
Clinical medicine defines dehydration using blood markers that confirm hypertonicity (serum sodium concentration ([Na+])>145 mmol/L) and intracellular dehydration. Sports medicine equates dehydration with a concentrated urine as defined by any urine osmolality (UOsm) ≥700 mOsmol/kgH2O or urine specific gravity (USG) ≥1.020. Objective: To compare blood versus urine indices of dehydration in a cohort of athletes undergoing routine screenings. Methods: 318 collegiate athletes (193 female) provided blood and urine samples and asked to rate how thirsty they were on a 10-point visual analogue scale. Serum was analysed for [Na+], while serum and UOsm were measured using an osmometer. USG was measured using a Chemstrip. Data were categorised into dehydrated versus hydrated groupings based on these UOsm and USG thresholds. Results: Using UOsm ≥700 mOsmol/kgH2O to define dehydration, 55% of athletes were classified as dehydrated. Using any USG ≥1.020 to define dehydration, 27% of these same athletes were classified as dehydrated. No athlete met the clinical definition for dehydration (hypertonicity; serum [Na+]>145 mmol/L). Normonatremia (serum [Na+] between 135 mmol/L and 145 mmol/L) was maintained in 99.7% of athletes despite wide variation in UOsm (110–1298 mOsmol/kgH2O). A significant correlation was confirmed between serum [Na+] versus UOsm (r=0.18; P<0.01), although urine concentration extremes did not reflect derangement in serum markers or thirst rating. Conclusion: Urine concentration thresholds classified 27%–55% of collegiate athletes as dehydrated, while no athlete was dehydrated according to blood [Na+] measurement. Practitioners should caution against using urine indices to diagnose or monitor dehydration, because urinary output is a response rather than a reflection of (tightly regulated) blood tonicity.

19 January 2015 in Physiological Reports
Verified
Journal Article
Open access
PDF file
Tamara D Hew-ButlerTamara D Hew-Butler
Tamara D Hew-Butler
KLKristin Landis-Piwowar
Kristin Landis-Piwowar
GBGregory Byrd
Gregory Byrd
MSMax Seimer
Max Seimer
NSNicole Seigneurie
Nicole Seigneurie
OMOtto Muzik
Otto Muzik
Irisin is a hormone which mimics the favorable metabolic effects associated with regular exercise, by converting subcutaneous white fat into brownish fat, in rodents. Thirty‐three human subjects (16 runners, 17 nonrunners) were measured for: resting energy expenditure (REE), body composition, VO2 Peak test, [irisin]p, and plasma metabolic profile. Nine female nonrunners then participated in a 10‐week supervised 5 km training program and tested after the race. Two runners underwent 18F‐FDG‐PET scans to quantify brown fat. No gender or age (28 ± 10 years) differences noted between matched cohorts. Runners averaged 58 ± 26 miles/week for 13 ± 6 years and had lower bodyweight (63 vs. 88 kg; P < 0.001), BMI (21 vs. 30 kg/m2; P < 0.0001), triglycerides (58 vs. 123 mg/dL; P < 0.01), total (white) fat (14 vs. 32%; P < 0.0001), and had higher VO2 Peak (63 vs. 34 mL/kg‐min; P < 0.0001) and HDL (65 vs. 48 mg/dL; P < 0.01) compared with nonrunners. [Irisin]p was lower in runners versus nonrunners both before (179 vs. 197 ng/mL; NS) and after (207 vs. 226 ng/mL; NS) the VO2 Peak test. Significant ( P < 0.05) positive correlations were noted between [irisin]p versus BMI ( r 2 = 0.15), triglycerides ( r 2 = 0.40), and total body fat(g) ( r 2 = 0.24) with a significant negative correlation between [irisin]p versus respiratory quotient ( r 2 = 0.33). Total lean mass significantly correlated with REE ( r 2 = 0.58) while total fat mass inversely correlated with VO2 Peak ( r 2 = 0.64). Nonrunners had lower [irisin]p after completion of the training program (194 vs.181 ng/mL; pre‐ to post‐training; P > 0.05). Neither runner selected for 18F‐FDG‐PET scans had brown fat. Runners demonstrated significantly healthier metabolic and body composition profiles compared with nonrunners. None of these favorable exercise effects were positively associated with [irisin]p..

7 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Tamara D Hew-ButlerTamara D Hew-Butler
Tamara D Hew-Butler
VSValerie Smith-Hale
Valerie Smith-Hale
APAlyssa Pollard-McGrandy
Alyssa Pollard-McGrandy
MVMatthew VanSumeren
Matthew VanSumeren
The detrimental effects of dehydration, to both mental and physical health, are well-described. The potential adverse consequences of overhydration, however, are less understood. The difficulty for most humans to routinely ingest ≥2 liters (L)—or “eight glasses”—of water per day highlights the likely presence of an inhibitory neural circuit which limits the deleterious consequences of overdrinking in mammals but can be consciously overridden in humans. This review summarizes the existing data obtained from both animal (mostly rodent) and human studies regarding the physiology, psychology, and pathology of overhydration. The physiology section will highlight the molecular strength and significance of aquaporin-2 (AQP2) water channel downregulation, in response to chronic anti-diuretic hormone suppression. Absence of the anti-diuretic hormone, arginine vasopressin (AVP), facilitates copious free water urinary excretion (polyuria) in equal volumes to polydipsia to maintain plasma tonicity within normal physiological limits. The psychology section will highlight reasons why humans and rodents may volitionally overdrink, likely in response to anxiety or social isolation whereas polydipsia triggers mesolimbic reward pathways. Lastly, the potential acute (water intoxication) and chronic (urinary bladder distension, ureter dilation and hydronephrosis) pathologies associated with overhydration will be examined largely from the perspective of human case reports and early animal trials.

1 September 2014 in Journal of Science and Medicine in Sport
Verified
Journal Article
Closed access
BOBethan E. Owen
Bethan E. Owen
IRIan R. Rogers
Ian R. Rogers
Martin HoffmanMartin Hoffman
Martin Hoffman
KSKristin J. Stuempfle
Kristin J. Stuempfle
DLDouglas Lewis
Douglas Lewis
Tamara D Hew-ButlerTamara D Hew-Butler
Tamara D Hew-Butler